These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12209660)

  • 21. Association between sexual behavior and cervical cancer screening.
    Smith AM; Heywood W; Ryall R; Shelley JM; Pitts MK; Richters J; Simpson JM; Patrick K
    J Womens Health (Larchmt); 2011 Jul; 20(7):1091-6. PubMed ID: 21682554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up.
    Massad LS; Seaberg EC; Wright RL; Darragh T; Lee YC; Colie C; Burk R; Strickler HD; Watts DH
    Obstet Gynecol; 2008 Jun; 111(6):1388-93. PubMed ID: 18515523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytological screening for cervical cancer in the province of Limburg, Belgium.
    Arbyn M; Van Nieuwenhuyse A; Bogers J; De Jonge E; De Beeck LO; Matheï C; Buntinx F
    Eur J Cancer Prev; 2011 Jan; 20(1):18-24. PubMed ID: 20805755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S; Wronski I; Murray R; Cox H
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An audit of the cervical cancer screening histories of 246 women with carcinoma.
    Duggan MA; Nation J
    J Low Genit Tract Dis; 2012 Jul; 16(3):263-70. PubMed ID: 22297213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
    Linder J; Zahniser D
    Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Papanicolaou smear as a sentinel screening test for health screening in women.
    Hueston WJ; Stiles MA
    Arch Intern Med; 1994 Jul; 154(13):1473-7. PubMed ID: 8018002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An epidemiologic study of Pap screening histories in women with invasive carcinomas of the uterine cervix.
    Nasca PC; Ellish N; Caputo TA; Saboda K; Metzger B
    N Y State J Med; 1991 Apr; 91(4):152-6. PubMed ID: 2047031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Encouraging underscreened women to have cervical cancer screening: the effectiveness of a computer strategy.
    Campbell E; Peterkin D; Abbott R; Rogers J
    Prev Med; 1997; 26(6):801-7. PubMed ID: 9388791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a new cervical pap smear screening guideline on member perceptions and comfort levels.
    Rolnick SJ; LaFerla JJ; Jackson J; Akkerman D; Compo R
    Prev Med; 1999 May; 28(5):530-4. PubMed ID: 10329344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of Papanicolaou testing and contacts with the medical care system to stage at diagnosis of cervical cancer.
    Norman SA; Talbott EO; Kuller LH; Stolley PD; Dunn MS; Baffone K; Klionsky B; Weinberg GB
    Arch Intern Med; 1991 Jan; 151(1):58-64. PubMed ID: 1985610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a call/recall system in improving compliance with cervical cancer screening: a randomized controlled trial.
    Buehler SK; Parsons WL
    CMAJ; 1997 Sep; 157(5):521-6. PubMed ID: 9294390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer screening programme in Primorsko-Goranska County, Croatia--the results of the pilot study.
    Vrdoljak-Mozetic D; Ostojić DV; Stemberger-Papić S; Janković S; Glibotić-Kresina H; Brncić-Fischer A; Benić-Salamon K
    Coll Antropol; 2010 Mar; 34(1):225-32. PubMed ID: 20437641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
    Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
    Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
    Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.